2018 and Beyond: Poland Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in Poland witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Poland and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Poland healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Poland healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Poland pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Poland and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Poland healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Poland healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Poland pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Poland Pharmaceutical and Healthcare Industry Snapshot
2.2 Poland Pharmaceuticals Market Overview
3 POLAND PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Poland
3.2 Drivers and Restraints
3.2.1 Market Drivers in Poland Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Poland Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 POLAND PHARMACEUTICAL MARKET OUTLOOK
4.1 Poland Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Poland Pharmaceutical Exports, $ million, 2015- 2025
4.3 Poland Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Poland (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Poland (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Poland Prescription Drug Sales, $ Million, 2015- 2025
4.7 Poland Generic Drug Sales, $ Million, 2015- 2025
5 POLAND HEALTHCARE MARKET OUTLOOK
5.1 Poland Healthcare Expenditure Outlook, 2015- 2025
5.2 Poland Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Poland Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Poland Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Poland, 2015- 2025
6 POLAND HEALTHCARE MARKET STATISTICS
6.1 Poland Mortality by Disease Category, 2017
6.2 Number of Hospitals in Poland, 2007- 2017
6.3 Number of Hospital Beds in Poland, 2007- 2017
6.4 Physicians Count in Poland, 2007- 2017
6.5 Pharmacists Count in Poland, 2007- 2017
7 POLAND CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Poland, 2017
7.2 Ongoing Clinical Trials by Disease Category in Poland, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 POLAND DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Poland Population Forecast by Age Group, 2005- 2025
8.2 Poland Population Forecast by Location, 2005- 2025
8.3 Poland GDP Forecast, 2005- 2025
8.4 Poland GDP Per Capita Forecast, 2005- 2025
8.5 Poland Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN POLAND PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Poland Pharmaceutical and Healthcare Industry Snapshot
2.2 Poland Pharmaceuticals Market Overview
3 POLAND PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Poland
3.2 Drivers and Restraints
3.2.1 Market Drivers in Poland Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Poland Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 POLAND PHARMACEUTICAL MARKET OUTLOOK
4.1 Poland Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Poland Pharmaceutical Exports, $ million, 2015- 2025
4.3 Poland Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Poland (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Poland (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Poland Prescription Drug Sales, $ Million, 2015- 2025
4.7 Poland Generic Drug Sales, $ Million, 2015- 2025
5 POLAND HEALTHCARE MARKET OUTLOOK
5.1 Poland Healthcare Expenditure Outlook, 2015- 2025
5.2 Poland Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Poland Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Poland Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Poland, 2015- 2025
6 POLAND HEALTHCARE MARKET STATISTICS
6.1 Poland Mortality by Disease Category, 2017
6.2 Number of Hospitals in Poland, 2007- 2017
6.3 Number of Hospital Beds in Poland, 2007- 2017
6.4 Physicians Count in Poland, 2007- 2017
6.5 Pharmacists Count in Poland, 2007- 2017
7 POLAND CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Poland, 2017
7.2 Ongoing Clinical Trials by Disease Category in Poland, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 POLAND DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Poland Population Forecast by Age Group, 2005- 2025
8.2 Poland Population Forecast by Location, 2005- 2025
8.3 Poland GDP Forecast, 2005- 2025
8.4 Poland GDP Per Capita Forecast, 2005- 2025
8.5 Poland Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN POLAND PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
